678 related articles for article (PubMed ID: 11908556)
1. High levels of interleukin 13 in rheumatoid arthritis sera are modulated by tumor necrosis factor antagonist therapy: association with dendritic cell growth activity.
Tokayer A; Carsons SE; Chokshi B; Santiago-Schwarz F
J Rheumatol; 2002 Mar; 29(3):454-61. PubMed ID: 11908556
[TBL] [Abstract][Full Text] [Related]
2. Soluble receptors for tumor necrosis factor and interleukin-2 in serum and synovial fluid of patients with rheumatoid arthritis, reactive arthritis and osteoarthritis.
Steiner G; Studnicka-Benke A; Witzmann G; Höfler E; Smolen J
J Rheumatol; 1995 Mar; 22(3):406-12. PubMed ID: 7783054
[TBL] [Abstract][Full Text] [Related]
3. Evidence that anti-tumor necrosis factor therapy with both etanercept and infliximab induces apoptosis in macrophages, but not lymphocytes, in rheumatoid arthritis joints: extended report.
Catrina AI; Trollmo C; af Klint E; Engstrom M; Lampa J; Hermansson Y; Klareskog L; Ulfgren AK
Arthritis Rheum; 2005 Jan; 52(1):61-72. PubMed ID: 15641091
[TBL] [Abstract][Full Text] [Related]
4. IgG antibodies to type II collagen reflect inflammatory activity in patients with rheumatoid arthritis.
Kim WU; Yoo WH; Park W; Kang YM; Kim SI; Park JH; Lee SS; Joo YS; Min JK; Hong YS; Lee SH; Park SH; Cho CS; Kim HY
J Rheumatol; 2000 Mar; 27(3):575-81. PubMed ID: 10743792
[TBL] [Abstract][Full Text] [Related]
5. Induction of tumour necrosis factor receptor-expressing macrophages by interleukin-10 and macrophage colony-stimulating factor in rheumatoid arthritis.
Takasugi K; Yamamura M; Iwahashi M; Otsuka F; Yamana J; Sunahori K; Kawashima M; Yamada M; Makino H
Arthritis Res Ther; 2006; 8(4):R126. PubMed ID: 16859503
[TBL] [Abstract][Full Text] [Related]
6. Increased levels of interleukin 33 in sera and synovial fluid from patients with active rheumatoid arthritis.
Matsuyama Y; Okazaki H; Tamemoto H; Kimura H; Kamata Y; Nagatani K; Nagashima T; Hayakawa M; Iwamoto M; Yoshio T; Tominaga S; Minota S
J Rheumatol; 2010 Jan; 37(1):18-25. PubMed ID: 19918048
[TBL] [Abstract][Full Text] [Related]
7. Immune complexes from rheumatoid arthritis synovial fluid induce FcgammaRIIa dependent and rheumatoid factor correlated production of tumour necrosis factor-alpha by peripheral blood mononuclear cells.
Mathsson L; Lampa J; Mullazehi M; Rönnelid J
Arthritis Res Ther; 2006; 8(3):R64. PubMed ID: 16569263
[TBL] [Abstract][Full Text] [Related]
8. Tumor necrosis factor blockade differentially affects innate inflammatory and Th17 cytokines in rheumatoid arthritis.
Zivojinovic SM; Pejnovic NN; Sefik-Bukilica MN; Kovacevic LV; Soldatovic II; Damjanov NS
J Rheumatol; 2012 Jan; 39(1):18-21. PubMed ID: 22133625
[TBL] [Abstract][Full Text] [Related]
9. Synovial fluid induced nuclear factor-kappaB DNA binding in a monocytic cell line.
Lehmann T; Nguyen LQ; Handel ML
J Rheumatol; 2000 Dec; 27(12):2769-76. PubMed ID: 11128662
[TBL] [Abstract][Full Text] [Related]
10. Highly increased levels of tumor necrosis factor-alpha and other proinflammatory cytokines in psoriatic arthritis synovial fluid.
Partsch G; Steiner G; Leeb BF; Dunky A; Bröll H; Smolen JS
J Rheumatol; 1997 Mar; 24(3):518-23. PubMed ID: 9058659
[TBL] [Abstract][Full Text] [Related]
11. Potential novel biomarkers of disease activity in rheumatoid arthritis patients: CXCL13, CCL23, transforming growth factor alpha, tumor necrosis factor receptor superfamily member 9, and macrophage colony-stimulating factor.
Rioja I; Hughes FJ; Sharp CH; Warnock LC; Montgomery DS; Akil M; Wilson AG; Binks MH; Dickson MC
Arthritis Rheum; 2008 Aug; 58(8):2257-67. PubMed ID: 18668547
[TBL] [Abstract][Full Text] [Related]
12. Relationship of serum TWEAK level to cytokine level, disease activity, and response to anti-TNF treatment in patients with rheumatoid arthritis.
Park MC; Chung SJ; Park YB; Lee SK
Scand J Rheumatol; 2008; 37(3):173-8. PubMed ID: 18465450
[TBL] [Abstract][Full Text] [Related]
13. Resistance of rheumatoid synovial dendritic cells to the immunosuppressive effects of IL-10.
MacDonald KP; Pettit AR; Quinn C; Thomas GJ; Thomas R
J Immunol; 1999 Nov; 163(10):5599-607. PubMed ID: 10553089
[TBL] [Abstract][Full Text] [Related]
14. Elevated concentrations of monocyte derived cytokines in synovial fluid of children with enthesitis related arthritis and polyarticular types of juvenile idiopathic arthritis.
Saxena N; Aggarwal A; Misra R
J Rheumatol; 2005 Jul; 32(7):1349-53. PubMed ID: 15996076
[TBL] [Abstract][Full Text] [Related]
15. Analysis of SF and plasma cytokines provides insights into the mechanisms of inflammatory arthritis and may predict response to therapy.
Wright HL; Bucknall RC; Moots RJ; Edwards SW
Rheumatology (Oxford); 2012 Mar; 51(3):451-9. PubMed ID: 22179732
[TBL] [Abstract][Full Text] [Related]
16. Increased synovial fluid levels of interleukin-12, sCD25 and sTNF-RII/sTNF-RI ratio delineate a cytokine pattern characteristic of immune arthropathies.
Ribbens C; André B; Kaye O; Kaiser MJ; Bonnet V; de Groote D; Franchimont N; Malaise MG
Eur Cytokine Netw; 2000 Dec; 11(4):669-76. PubMed ID: 11125312
[TBL] [Abstract][Full Text] [Related]
17. Interleukin 8 and monocyte chemoattractant protein-1 in patients with juvenile rheumatoid arthritis. Relation to onset types, disease activity, and synovial fluid leukocytes.
De Benedetti F; Pignatti P; Bernasconi S; Gerloni V; Matsushima K; Caporali R; Montecucco CM; Sozzani S; Fantini F; Martini A
J Rheumatol; 1999 Feb; 26(2):425-31. PubMed ID: 9972980
[TBL] [Abstract][Full Text] [Related]
18. Anti-tumor necrosis factor therapy increases synovial osteoprotegerin expression in rheumatoid arthritis.
Catrina AI; af Klint E; Ernestam S; Catrina SB; Makrygiannakis D; Botusan IR; Klareskog L; Ulfgren AK
Arthritis Rheum; 2006 Jan; 54(1):76-81. PubMed ID: 16385498
[TBL] [Abstract][Full Text] [Related]
19. Tumor necrosis factor alpha blockade treatment down-modulates the increased systemic and local expression of Toll-like receptor 2 and Toll-like receptor 4 in spondylarthropathy.
De Rycke L; Vandooren B; Kruithof E; De Keyser F; Veys EM; Baeten D
Arthritis Rheum; 2005 Jul; 52(7):2146-58. PubMed ID: 15986373
[TBL] [Abstract][Full Text] [Related]
20. Synovial fluid levels of tumor necrosis factor alpha and oncostatin M correlate with levels of markers of the degradation of crosslinked collagen and cartilage aggrecan in rheumatoid arthritis but not in osteoarthritis.
Manicourt DH; Poilvache P; Van Egeren A; Devogelaer JP; Lenz ME; Thonar EJ
Arthritis Rheum; 2000 Feb; 43(2):281-8. PubMed ID: 10693867
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
